BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis

ABSTRACT: Metabolomic analysis of BET inhibitor treated DLBCL cells: DOHH2 and WSU-DLCL-2 cells were treated with JQ1, I-BET151 or I-BET762 for 24 h. The cellular concentrations of the indicated metabolites were quantified by mass spectrometry and normalized to the solvent control.

ORGANISM(S): Homo sapiens (human)

SUBMITTER:  

PROVIDER: S-BSST1072 | biostudies-other |

REPOSITORIES: biostudies-other